Intracardiac thrombi in pediatric patients: presentation profiles and clinical outcomes

J B John1, S G Cron, G C Kung

  • 1Section of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, 6621 Fannin, Houston, TX, USA. jbjohn@kidshearts.com

Pediatric Cardiology
|April 4, 2007
PubMed

Insights

Pediatric intracardiac thrombi (ICT) often resolve with medical therapy, but larger thrombi pose a significant embolization risk. Outcomes vary based on underlying conditions like dilated cardiomyopathy or Fontan operation.

Area of Science:

  • Cardiology
  • Pediatric Medicine
  • Hematology

Background:

  • Intracardiac thrombi (ICT) are a serious concern in pediatric patients.
  • Understanding their presentation, treatment, and outcomes is crucial for clinical management.

Purpose of the Study:

  • To analyze the characteristics, treatment strategies, and clinical outcomes of pediatric patients with ICT.
  • To identify risk factors for embolization and mortality in this population.

Main Methods:

  • Retrospective review of 31 pediatric patients diagnosed with ICT via echocardiography over 10 years.
  • Analysis of ICT characteristics (size, location, morphology), treatment (medical vs. thrombectomy), and patient outcomes (embolization, morbidity, mortality).
  • Stratification of patients into groups based on underlying conditions: dilated cardiomyopathy, post-Fontan operation, and other diagnoses.

Main Results:

  • Forty ICT were diagnosed in 31 pediatric patients (mean age 8.8 years).
  • Overall mortality was 39%, with only one death attributed to ICT embolization.
  • Embolic events occurred in 13% of patients; larger ICT showed a higher tendency to embolize.
  • Medical therapy led to resolution in 63% of cases; surgical thrombectomy was rarely needed.
  • Patients with dilated cardiomyopathy had a poorer prognosis, with 8 deaths among 11 patients.

Conclusions:

  • Intracardiac thrombi in pediatric patients frequently resolve with medical management.
  • Larger ICT size and specific underlying conditions (e.g., dilated cardiomyopathy, post-Fontan) are associated with increased embolic risk and poorer outcomes.
  • While ICT embolization can cause significant morbidity, it is rarely the primary cause of mortality.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...